Delfi Diagnostics logo

Delfi Diagnostics, Inc.

Biotechnology

Delfi Diagnostics Stock

Delfi Diagnostics is a biotechnology company specializing in the development of advanced blood test systems for early cancer detection. Its innovative technology uses machine learning to analyze blood and genome samples, identifying cancer-associated DNA fragments.

Management Team

Susan Tousi Chief Executive Officer
Victor Velculescu Co-Founder & Board Member
Jennifer Buechel Chief Operating Officer & President
Doug Schenkel Chief Financial Officer & Head of Strategy
Nicholas Dracopoli Co-Founder & Chief Scientific Officer
Jessica Meng Chief Commercial Officer
Alessandro Leal Co-Founder & Medical Director of Translational Research
Robert Scharpf Co-Founder & Head of Computational Biology
Peter Bach Chief Medical Officer

Funding Information